LONDON--(BUSINESS WIRE)--The stem cell therapy market is expected to grow by USD 588.22 mn, progressing at a CAGR of almost 7% during the forecast period.
Click & Get Free Sample Report in Minutes
The increase in awareness of stem cell therapy is one of the major factors propelling market growth. However, factors such as the high cost of clinical trials will hamper the market growth.
More details: https://www.technavio.com/report/stem-cell-therapy-market-industry-analysis
Stem Cell Therapy Market: Type Landscape
Based on the type, the allogeneic transplants segment is expected to witness lucrative growth during the forecast period.
Stem Cell Therapy Market: Geographic Landscape
By geography, North America is going to have a lucrative growth during the forecast period. About 51% of the market’s overall growth is expected to originate from North America. The US and Canada are the key markets for the stem cell therapy market in North America.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
Related Reports on Health Care Include:
-
Point of Care Diagnostics Market by Product, End-user, and Geography - Forecast and Analysis 2020-2024- The point of care diagnostics market size has the potential to grow by USD 10.69 billion during 2020-2024. However, the market’s growth momentum will decelerate during the forecast period. To get extensive research insights: Click and get a FREE sample report in minutes
- Prostate Biopsy Market by Product, End-user, and Geography - Forecast and Analysis 2020-2024- The prostate biopsy market size has the potential to grow by USD 380.23 million during 2020-2024, and the market’s growth momentum will accelerate during the forecast period. To get extensive research insights: Click and get a FREE sample report in minutes
Companies Covered:
- Gilead Sciences Inc.
- Holostem Terapie Avanzate Srl
- Lineage Cell Therapeutics Inc.
- Lonza Group Ltd.
- Novartis AG
- Nuvasive Inc.
- Organogenesis Inc.
- Osiris Therapeutics Inc.
- RTI Surgical Holdings Inc.
- Vericel Corp.
What our reports offer:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers market data for 2019, 2020, until 2024
- Market trends (drivers, opportunities, threats, challenges, investment opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Key Topics Covered:
Executive Summary
Market Landscape
- Market ecosystem
- Market characteristics
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Type
- Market segments
- Comparison by Type
- Allogeneic transplants - Market size and forecast 2019-2024
- Autologous transplants - Market size and forecast 2019-2024
- Market opportunity by Type
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- APAC - Market size and forecast 2019-2024
- South America - Market size and forecast 2019-2024
- MEA - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Vendor landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Gilead Sciences Inc.
- Holostem Terapie Avanzate Srl
- Lineage Cell Therapeutics Inc.
- Lonza Group Ltd.
- Novartis AG
- Nuvasive Inc.
- Organogenesis Inc.
- Osiris Therapeutics Inc.
- RTI Surgical Holdings Inc.
- Vericel Corp.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
